|

HBI 0201-ESO TCRT Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Hadassah Medical Organization1

Indications

  • Neuroblastoma, Metastatic1
  • Sarcoma, Synovial1
  • Melanoma Stage IV1
  • Bladder Urothelial Carcinoma1
  • Sarcoma,Soft Tissue1

Other1 trial

Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.